Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors
Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability, pharmacokinetic profile and treatment
effect of a new drug known as BGB-283 in patients with solid tumours.